摘要
BACKGROUND Several studies have been conducted to explore the association between the use of proton pump inhibitors (PPIs) and hepatic encephalopathy (HE) risk in patients with liver cirrhosis. However, their results are controversial. AIM To perform a systematic review and meta-analysis to evaluate the HE risk among PPI users. METHODS A systematic search on PubMed, Web of Science, EMBase, and ScienceDirect databases was conducted up to December 31, 2018 for eligible studies involving PPI use and HE risk. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using the fixed or random effects model. Publication bias was evaluated using Begg’s test, Egger’s test, and trim-and-fill method. RESULTS Seven studies with 4574 patients were included in the present meta-analysis. The meta-analysis results indicated a significant association between the PPI use and HE risk (OR = 1.50;95%CI: 1.25-1.75) with low heterogeneity (I2 = 14.2%, P = 0.321). Although publication bias existed when Egger’s tests were used (P = 0.005), the trim-and-fill method verified the stability of the pooled result. Sensitivity analyses suggested that the results of this meta-analysis were robust. CONCLUSION The current evidence indicates that PPI use increases HE risk in patients with liver cirrhosis. Further studies with a large data set and well-designed models are needed to validate our findings.
BACKGROUND Several studies have been conducted to explore the association between the use of proton pump inhibitors(PPIs) and hepatic encephalopathy(HE) risk in patients with liver cirrhosis. However, their results are controversial.AIM To perform a systematic review and meta-analysis to evaluate the HE risk among PPI users.METHODS A systematic search on PubMed, Web of Science, EMBase, and ScienceDirect databases was conducted up to December 31, 2018 for eligible studies involving PPI use and HE risk. Odds ratios(ORs) and 95% confidence intervals(CIs) were calculated using the fixed or random effects model. Publication bias was evaluated using Begg’s test, Egger’s test, and trim-and-fill method.RESULTS Seven studies with 4574 patients were included in the present meta-analysis. The meta-analysis results indicated a significant association between the PPI use and HE risk(OR = 1.50; 95%CI: 1.25-1.75) with low heterogeneity(I2 = 14.2%, P =0.321). Although publication bias existed when Egger’s tests were used(P =0.005), the trim-and-fill method verified the stability of the pooled result.Sensitivity analyses suggested that the results of this meta-analysis were robust.CONCLUSION The current evidence indicates that PPI use increases HE risk in patients with liver cirrhosis. Further studies with a large data set and well-designed models are needed to validate our findings.
作者简介
Corresponding author: Yong Li, MD, Chief Doctor, Emergency Department, Cangzhou Central Hospital, No. 16, Xinhua Road, Yunhe Qu, Cangzhou 061000, Hebei Province, China. ly13333367871@hotmail.com Telephone:+86-13333367871 Fax:+86-0317-2075685.
